Countries that embrace legal regulation find themselves in breach of international law. In this video, we explain a strategy to resolve those treaty tensions and to enable progressive and sustainable change at the global level.
Policy changes over the past five years or so have dramatically reshaped the global cannabis market. Not only has there been an unprecedented boom in medical markets, but following policy shifts in several jurisdictions a growing number of countries are also preparing for legal regulation of non-medical use. Such moves look set to bring a clear range of benefits in terms of health and human rights. As this groundbreaking Report, highlights, however, there are also serious concerns about the unfolding market dynamics.
Today marks the United Nations’ International Day Against Drug Abuse and Illicit Trafficking. Its origin can be traced back to the institutional architecture of the global drug control system which for the last five decades has served as a mechanism that regulates, controls, or prohibits the use and distribution of more than 300 psychoactive substances.
John Walsh, Martin Jelsma, Tom Blickman, David Bewley-Taylor
19 March 2019
The World Health Organization’s (WHO) Expert Committee on Drug Dependence (ECDD or Expert Committee) released in January 2019 the outcomes of the first-ever critical review of cannabis, recommending a series of changes in the current scheduling of cannabis-related substances under the UN drug control conventions.